Page last updated: 2024-08-17

adenosine monophosphate and Granulocytic Leukemia, Chronic

adenosine monophosphate has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Baruchel, A; Bertrand, Y; Boissel, N; Brethon, B; Ducassou, S; Gandemer, V; Halfon-Domenech, C; Leblanc, T; Leverger, G; Michel, G; Petit, A; Ray-Lunven, AF; Rohrlich, PS; Rouger-Gaudichon, J; Schneider, P; Sirvent, N; Strullu, M	1
Adiuto, D; Caricchi, P; De Angelis, V; Di Clemente, F; Fedeli, L; Ferrajoli, A; Garofani, P; Horisberger, MA; Liberati, AM; Palumbo, B	1

Reviews

1 review(s) available for adenosine monophosphate and Granulocytic Leukemia, Chronic

Article	Year
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bulletin du cancer, 2021, Volume: 108, Issue:5 Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Alanine; Antiviral Agents; Cancer Care Facilities; Child; Consolidation Chemotherapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Vaccines; Drug Interactions; France; Humans; Induction Chemotherapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Societies, Medical	2021

Article

Year

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).

Bulletin du cancer, 2021, Volume: 108, Issue:5

Topics: Adenosine Monophosphate; Adolescent; Adrenal Cortex Hormones; Alanine; Antiviral Agents; Cancer Care Facilities; Child; Consolidation Chemotherapy; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Vaccines; Drug Interactions; France; Humans; Induction Chemotherapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Maintenance Chemotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk Assessment; Societies, Medical

2021

Trials

1 trial(s) available for adenosine monophosphate and Granulocytic Leukemia, Chronic

Article	Year
Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia. Journal of interferon research, 1994, Volume: 14, Issue:6 Topics: Adenosine Monophosphate; Adult; Aged; Antiviral Agents; beta 2-Microglobulin; Biopterins; Female; GTP-Binding Proteins; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myxovirus Resistance Proteins; Neopterin; Protein Biosynthesis; Recombinant Proteins	1994

Article

Year

Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.

Journal of interferon research, 1994, Volume: 14, Issue:6

Topics: Adenosine Monophosphate; Adult; Aged; Antiviral Agents; beta 2-Microglobulin; Biopterins; Female; GTP-Binding Proteins; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myxovirus Resistance Proteins; Neopterin; Protein Biosynthesis; Recombinant Proteins

1994